National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Prostate Cancer Prevention (PDQ®)
Patient VersionHealth Professional VersionLast Modified: 08/26/2008
Cancer Incidence in Study of Clark: Randomized Trial of Selenium

Cancer Site   Selenium   Placebo   Hazard Ratio   P value 
Lung 17 31 .56 .05
Prostate 13 35 .35 .001
Colorectal 8 19 .39 .03
Head/neck 6 8 .77 .64
Bladder 8 6 1.27 .66
Esophageal 2 6 .30 .14
Breast 9 3 2.95 .11
Other carcinoma 5 9 .54 .27
Total carcinoma 59 104 .54 <.001
Melanoma 8 8 .92 .87
Leukemia 8 5 1.50 .48
Other noncarcinoma 3 3 .99 .99
Total noncarcinomas 19 16 1.16 .65
Total cancers 77 119 .61 <.001


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov